Comrod

The supplied evidence does not describe a brand called Comrod. The only source provided is a press release about Debiopharm, a privately owned Swiss biopharmaceutical company, and its MultiLINK linker technology for antibody-drug conjugates. That document contains no mention of Comrod, no product line, no ownership information, no headquarters, and no market activity attributable to a Comrod brand. Because the identity of this subject cannot be established from the evidence, this entry is intentionally kept short and flagged for review. It should not be confused with any non-commercial namesake, and no facts about Debiopharm or its MLINK Select, MLINK Duo, or MLINK HiSol technologies should be attributed to Comrod. If Comrod is a real commercial entity, additional primary sources such as an official website, corporate registry filing, or trade press coverage are needed before a full dossier can be written.

• Unconfirmed

  Reported2026.10.14

  Comrod completes acquisition of TransOpto[2]Comrod 完成对 TransOpto 的收购evertiq.com

  Norwegian communications company Comrod has completed the acquisition of TransOpto, a Kristiansand-based developer of wireless free-space optical data links, adding optical communications technology to Comrod's defence communications portfolio. Financial terms were not disclosed.

• Unconfirmed

  Reported2020.01.20

  Comrod acquires Sørskår Mekaniske Verksted[3]Comrod 收购 Sørskår Mekaniske Verkstedprnewswire.com

  Comrod announced its acquisition of Sørskår Mekaniske Verksted AS, a supplier of mechanical services to Comrod. Sørskår management and staff will remain with the company; its workshop is planned to relocate to Comrod at Tau in a new building scheduled for completion by June 2020.

Read more

1. 1Debiopharm's Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistancefinanznachrichten.de
2. 2Comrod 完成对 TransOpto 的收购evertiq.com
3. 3Comrod 收购 Sørskår Mekaniske Verkstedprnewswire.com